{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:40:00Z","timestamp":1791301200115,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.eplepsyres.2016.05.012","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T14:15:22Z","timestamp":1464444922000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study"],"prefix":"10.1016","volume":"125","author":[{"given":"Paola","family":"De Liso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Laschet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Barnerias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Leunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Desguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Nabbout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eplepsyres.2016.05.012_bib0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.eplepsyres.2016.05.012_bib0010","first-page":"CD010483","article-title":"Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy","volume":"19","author":"Brigo","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0015","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1528-1167.2012.03495.x","article-title":"Successful use of fenfluramine as an add-on treatment for Dravet syndrome","volume":"53","author":"Ceulemans","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.seizure.2010.12.017","article-title":"A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target","volume":"20","author":"Chhun","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0025","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0030","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0035","series-title":"Handbook of Clinical Neurology","first-page":"627","article-title":"Dravet syndrome (severe myoclonic epilepsy in infancy)","author":"Dravet","year":"2013"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2014.10.014","article-title":"Efficacy and tolerability of the ketogenic diet in Dravet syndrome comparison with various standard antiepileptic drug regimen","volume":"109","author":"Dressler","year":"2015","journal-title":"Epilepsy Res."},{"issue":"Suppl 2","key":"10.1016\/j.eplepsyres.2016.05.012_bib0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1167.2011.03001.x","article-title":"Dravet syndrome: the long-term outcome","volume":"52","author":"Genton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0050","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.eplepsyres.2014.02.008","article-title":"Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence","volume":"108","author":"Inoue","year":"2014","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eplepsyres.2015.03.012","article-title":"Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: a multicenter, open-label study in Japan","volume":"113","author":"Inoue","year":"2015","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0060","unstructured":"Joose, D., 2001. Echelle de D\u00e9veloppement Psychomoteur de la Premi\u00e8re enfance. Brunet-L\u00e9zine R\u00e9vis\u00e9. Editions et Applications Psychologiques."},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1528-1167.2007.01423.x","article-title":"Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data","volume":"49","author":"Kassa\u00ef","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2007-964867","article-title":"Topiramate in the treatment of highly refractory patients with Dravet syndrome","volume":"37","author":"Kr\u00f6ll-Seger","year":"2006","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2013.07.015","article-title":"Transition and transfer from pediatric to adult health care in epilepsy: a families\u2019 survey on Dravet syndrome","volume":"29","author":"Kuchenbuch","year":"2013","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0032-1307454","article-title":"Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome","volume":"43","author":"Lotte","year":"2012","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.eplepsyres.2016.05.012_bib0085","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1111\/j.1528-1167.2011.03107.x","article-title":"Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: a prospective pilot study","volume":"52","author":"Nabbout","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1750-1172-8-176","article-title":"Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy","volume":"13","author":"Nabbout","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2013.09.009","article-title":"Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: a pilot study","volume":"23","author":"Nicita","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/epi.12532","article-title":"Long-term course of Dravet syndrome: a study from an epilepsy center in Japan","volume":"55","author":"Takayama","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0105","series-title":"WPPSI-III: Echelle d\u2019Intelligence de Wechsler pour la p\u00e9riode Pr\u00e9scolaire et Primaire","author":"Wechsler","year":"2004"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0110","series-title":"WISC-IV: Echelle d\u2019Intelligence De Wechsler Pour Enfants","author":"Wechsler","year":"2005"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0115","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1111\/epi.12303","article-title":"Stiripentol in Dravet syndrome: results of a retrospective US study","volume":"54","author":"Wirrell","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2016.05.012_bib0120","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1528-1157.1999.tb02017.x","article-title":"The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy","volume":"40","author":"Wong","year":"1999","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121116300754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:34:12Z","timestamp":1760276052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121116300754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":24,"alternative-id":["S0920121116300754"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.05.012","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2016.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}